Clinical Values of Abnormal Expressions of GPC-3 and HIF-1α in Diagnosis and Prognosis of Hepotacellular Carcinoma

杨燕,姚登福,董志珍,姚宁华,邱历伟,吴玮,杨君伶

DOI: https://doi.org/10.19460/j.cnki.0253-3685.2010.15.005

2010-01-01

Abstract:Objective To study the clinical values of abnormal expressions of glypican 3(GPC-3) and hypoxia inducible factor-1 alpha (HIF-1α) in the diagnosis and prognosis of hepotacellular carcinoma(HCC).Methods The specimens of HCC and tumor-adjacent tissures from 36 HCC patients were collected by self-control method.The expression and cellular distribution of HIF-1α and GPC-3 were analyzed by immohistochemistry.Results The positive HIF-1α and GPC-3 were brown and granule-like,the former mainly presented in cytoplasm and around central vein and the latter well-distributed in cytoplasm and membrane.The positive incidence of HIF-1α was 80.6% in HCC,and 100% in the tumor-adjacent tissues(P 0.01).The HIF-1α expression was positively correlated with tumor size.The intensity of HIF-1α expression was negatively correlated with the differentiation of HCC,but was not correlated with tumor numbers,HBV infection or AFP level.The positive incidence of GPC-3 was 80.6% in HCC and 41.7% in the tumor-adjacent tissues (P 0.01).The positive GPC-3 expression was not correlated with differentiation grade,the number of tumor,AFP level or HBsAg positive.Conclusion Abnormal expressions of GPC-3 and HIF-1α could reflect the biological behavior of HCC,which may be taken as the useful molecular markers for evaluating the diagnosis of HCC and predicting its metastasis.